Brenda Furlow
2022
In 2022, Brenda Furlow earned a total compensation of $3M as Executive Vice President and General Counsel at Bio-Techne, a 34% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $915,560 |
---|---|
Option Awards | $1,124,838 |
Salary | $533,700 |
Stock Awards | $374,856 |
Other | $9,272 |
Total | $2,958,226 |
Furlow received $1.1M in option awards, accounting for 38% of the total pay in 2022.
Furlow also received $915.6K in non-equity incentive plan, $533.7K in salary, $374.9K in stock awards and $9.3K in other compensation.
Rankings
In 2022, Brenda Furlow's compensation ranked 1,229th out of 5,760 executives tracked by ExecPay. In other words, Furlow earned more than 78.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,229 out of 5,760 | 79th |
Division Manufacturing | 594 out of 3,136 | 81st |
Major group Chemicals And Allied Products | 218 out of 1,422 | 85th |
Industry group Drugs | 197 out of 1,323 | 85th |
Industry Biological Products, Except Diagnostic Substances | 44 out of 291 | 85th |
Source: SEC filing on September 14, 2022.
Furlow's colleagues
We found five more compensation records of executives who worked with Brenda Furlow at Bio-Techne in 2022.
2022
Charles Kummeth
Bio-Techne
Chief Executive Officer
2022
James Hippel
Bio-Techne
Chief Financial Officer
2022
David Eansor
Bio-Techne
Former President, Protein Sciences
2022
Kim Kelderman
Bio-Techne
President, Diagnostics and Genomics
2022
William Geist
Bio-Techne